The effects of [Arg 14, Lys 15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions

Autor: Broccardo, M., Linari, G., Guerrini, R., Agostini, S., Petrella, C., Improta, G. ^*

Publikováno v: In Peptides 2005 26(9):1590-1597

Selective tachykinin NK 3-receptor agonists stimulate in vitro exocrine pancreatic secretion in the guinea pig

Autor: Linari, G, Broccardo, M, Nucerito, V, Improta, G

Publikováno v: In Peptides 2002 23(5):947-953

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis

Autor: Petrella, C., Agostini, Simona, Alema, G. S., Casolini, P., Carpino, F., Giuli, C., Improta, G., Linari, G., Petrozza, V., Broccardo, M.

Publikováno v: Journal of Neurogastroenterology and Motility
Journal of Neurogastroenterology and Motility, Korean Society of Neurogastroenterology and Motility, 2010, 22 (11), pp.1248-+. ⟨10.1111/j.1365-2982.2010.01569.x⟩

International audience; Background Cannabinoids (CBs) evoke their effects by activating the cannabinoid receptor subtypes CB1-r and CB2-r and exert anti-inflammatory effects altering chemokine and cytokine expression. Various cytokines and chemokines

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::847d67225dd83c6ebe2d7b3731652e3a
https://hal.inrae.fr/hal-02664429